Related Experiment Videos
Interleukin-4 suppresses plasminogen activator inhibitor-2 formation in stimulated human monocytes
J A Hamilton1, G A Whitty, K Last
1Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville, Australia.
Insights
Interleukin-4 and dexamethasone reduce plasminogen activator inhibitor-2 (PAI-2) in human monocytes. These agents, along with interferon-gamma, modulate PAI-2 production, impacting inflammation and tissue resorption.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Plasminogen activator inhibitor-2 (PAI-2) is a key regulator in inflammatory processes.
- Monocytes play a crucial role in inflammation and tissue remodeling.
Purpose of the Study:
- To investigate the regulation of PAI-2 production in human monocytes by various stimuli.
- To explore the effects of Interleukin-4 (IL-4), dexamethasone, and Interferon-gamma (IFN-gamma) on PAI-2 expression.
Main Methods:
- Quantification of PAI-2 using enzyme-linked immunosorbent assay (ELISA).
- Measurement of PAI-2 mRNA levels via Northern analysis.
- Cultures of human monocytes treated with lipopolysaccharide (LPS), IL-4, dexamethasone, and IFN-gamma.
Main Results:
- Lipopolysaccharide (LPS) significantly increased both extracellular and cell-associated PAI-2 levels and PAI-2 mRNA.
- Interleukin-4 (IL-4) and dexamethasone inhibited LPS-induced PAI-2 formation and mRNA induction.
- Interferon-gamma (IFN-gamma) did not reverse the LPS effect but potentiated it, unlike IL-4.
Conclusions:
- IL-4 and dexamethasone effectively suppress PAI-2 synthesis in stimulated human monocytes.
- These findings highlight the modulatory role of monocytes/macrophages in controlling inflammation and connective tissue resorption.
- The study contributes to understanding how immune cells regulate inflammatory responses and tissue breakdown.
Abstract:
Using a specific enzyme-linked immunosorbent assay, plasminogen activator inhibitor-2 (PAI-2) was quantitated in cultures of human monocytes. Lipopolysaccharide (LPS) increased both extracellular and cell-associated PAI-2 levels, as well as PAI-2 mRNA measured by Northern analysis. Both the lymphokine, interleukin-4 (IL-4) (greater than or equal to 10 pmol/L), and the glucocorticoid, dexamethasone (100 nmol/L), inhibited PAI-2 formation and PAI-2 mRNA induction. Another lymphokine, interferon-gamma (IFN-gamma) (100 U/mL), as for IL-4 alone, did not stimulate PAI-2 formation; however, in contrast to IL-4, IFN-gamma did not reverse the LPS effect but could potentiate it. The suppression of PAI-2 formation by IL-4 and glucocorticoid in stimulated human monocytes extends the list of monocyte products whose synthesis can be downregulated in these cells by the two agents. The findings could have relevance to the control by monocytes/macrophages of connective tissue resorption, including that of fibrin, at sites of inflammation.